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Background. Chronic neonatal pain can lead to long-term adverse effects on the immature brain. EDIN scale for prolonged pain
might not be fully suitable for premature infants. We aimed to test a modified EDIN scale, adding postmenstrual age (PMA) as
a sixth item (EDIN6). Methods. In a two-phase prospective study, pain was assessed in all neonates admitted in our NICU. In 𝑇1
EDIN was applied; in 𝑇2 EDIN6 with additional scores of 2, 1, and 0, respectively, for 25–32, 33–37, and >37 weeks PCA was tested.
Scores > 6 suggested pain. The nursing staff was given a questionnaire to evaluate EDIN and EDIN6. Results. A total of 15960 pain
assessments were recorded (8693 in 𝑇1; 7267 in 𝑇2). With EDIN6, cumulative detection of pain almost tripled (117/7267 versus
52/8693, 𝑝 = 0.001). Main differences were found among less mature categories (50/1472 versus 17/1734, 𝑝 = 0.001 in PCA 25–32;
26/2606 versus 10/4335, 𝑝 = 0.001 in PMA 33–37; 41/3189 versus 25/2624, 𝑝 = 0.26 in PMA > 37). Adequacy of pain assessment
in lower PMA was judged “medium-high” in 13,4% of nurses in 𝑇1 and 71,4% in 𝑇2. Conclusions. EDIN6 may allow improved
evaluation of pain in preterm infants.
1. Introduction
In the 1980s Anand and Hickey have described for the first
time the potential mechanisms, by which neonates experi-
ence pain [1, 2]. Since then, progress has beenmade in under-
standing and treating neonatal pain [2, 3]. There is a growing
concern for potential adverse long-term effects of recurrent
pain on the developing brain, altering pain responses later
in life [4]. Neuroradiological studies have proven the relation
between early pain exposure in preterm babies and impaired
brain development, in terms of size [5] and architecture [6]
of the brain. Although the literature has been prolific on
the topic, proposing many validated tools for neonatal pain
assessment, most of them focus on acute and procedural pain
[7]. A gold-standard measure for chronic pain is still lacking
[8]. Currently, alternative available scales for chronic pain are,
among others, EDIN [9], N-PASS [10], and COMFORTneo
[11].
EDIN scale (E´chelle de Douleur et d’Inconfort du
Nouveau-ne´) is a one-dimensional behavioral scale, based
on the assessment of 5 items: (1) facial expression, (2) body
movements, (3) quality of sleep, (4) quality of contact with
nurses, and (5) consolability; each of them is scored from 0
to 3; EDIN scores greater than 6 are considered expression
of pain. This scale is easily applicable, as it does not require
specific training [9]. Behavioral indicators may be affected by
many factors, such as gestational age (GA), postmenstrual age
(PMA), illness severity, continuous sedation, and cumulative
experience of previous invasive procedures, leading to “sen-
sitization” and “hyperalgesia” phenomena [12–14]. Moreover,
when pain persists, physiologic indicators (such as heart rate,
blood pressure, oxygen saturation, and breathing pattern)
could stay unchanged, and reactions to prolonged pain could
be more subtle and challenging to recognize, especially in the
preterm baby [15]. All these factors may contribute to under-
estimation and undertreatment of pain [8, 15]. Among these
aspects, age significantly seems to affect pain expression,
altering basic behavioral state (asleep/awake) of neonates and
their response to pain [16]. In 2009 Ancora and coworkers
retrospectively analyzed the impact of GA and PMA on the
expression of prolonged pain assessed by EDIN scale [16].
They found a relationship between GA and EDIN scores,
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reporting higher EDIN scores with increasing GA. More
mature babies were thought to be more able to express
pain if compared to their less mature counterparts. The
authors concluded that the validity of the EDIN scale could
be improved by taking into account GA and by attributing
higher basal scores to more premature neonates.
Aim. In the present study, we tested a modified EDIN scale,
named “EDIN6”. PMA was added as a sixth, nonbehavioral
item. Our aim was to evaluate prospectively how the use of
such an implemented scale could improve the management
of chronic pain in critically ill neonates. The second research
question addressed neonatal nurses’ perceptions of reliability
and clinical utility of EDIN6 versus EDIN scale in neonatal
pain assessment.
2. Materials and Methods
This prospective observational study was performed between
24th November 2013 and 23rd March 2014 at our institution,
Fondazione IRCCS Ospedale Maggiore Ca` Granda in Milan.
All neonates admitted to the 23-bed Neonatal Intensive Care
Unit (NICU) and 33-bed Medium Care in that period were
eligible. The patient population included term and preterm
neonates of all GA, with both medical and surgical diseases
and variable lengths of stay (LOS). No exclusion criteria
were considered.Themethodology followed the international
guidelines for the observational studies is called STROBE
[17].
By the Italian guidelines and recommendations for pre-
vention and treatment of neonatal pain [18], in our NICU
prolonged pain is routinely assessed by nursing staff, at least
once during the observation period of a shift, using EDIN
scale.The frequency of assessmentmay be increased, depend-
ing on ongoing analgesic therapy or painful events.The score
is reported in each patient’s electronic medical chart (Neo-
care), to tailor intensive care. A total score > 6 is indicative
of pain. Throughout the study period, analgosedation was
provided according to hospital-based protocols. Nonphar-
macological interventions consisted of sensorial saturation,
sucking, individualized developmental care, environmental
care, wrapping, and parental presence [18].Thepharmacolog-
ical approach included paracetamol (mild to moderate pain)
and opioids such as morphine and fentanyl (for moderate to
severe pain).
We were relieved from the need for approval from the
Institutional Review Board because of the noninvasive and
purely observational character of the study. However, parents
were informed of the ongoing study, and a written parental
consent was collected.
2.1. Procedure and Timing of the Study. In November 2013,
in a definite time (𝑡0), a structured researcher-developed
questionnaire (see Appendix), designed to evaluate the clin-
ical utility of EDIN scale, was administered to participating
nurses.
From November 2013, during a period of 60 days (𝑡1),
EDIN scores were obtained for each patient and collected in
the electronicmedical charts (Neocare). For each EDIN score
> 6, data concerning frequency and modality of additional
analgesic treatment were recorded.
From January 2014 toMarch 2014, for 60 days (𝑡2), EDIN6
scale was applied, following the same procedure as in 𝑡1.
At the end of this second period, in March 2014, in a
definite time (𝑡3), a similar questionnaire (see Appendix)
was administered to the nursing staff, evaluating EDIN6’s
performance.
2.2. Scales. EDINwas applied in 𝑡1, while EDIN6 was applied
in 𝑡2. The latter was modified from the EDIN scale, by intro-
ducing PMA as an additional item, according to the analysis
conducted by Ancora et al. [16]. This change provided two
additional points to the PMA< 33weeks, one additional point
for PMA between 33 and 37 weeks, and no additional points
for PMA > 37 weeks (Table 1).
Interrater reliability was calculated for 10% of the cases in
both populations (𝑡1 and 𝑡2).
2.3. Questionnaires. The nursing staff was administered a
researcher-developed questionnaire, to assess caregivers’ per-
ceptions about EDIN (in 𝑡0) and EDIN6 (in 𝑡3) as pain
assessment tools. Both versions (see Appendix) consist of
eleven questions, divided into twomain sections: the first one
is identical for EDIN and EDIN6, while the second is scale
specific. Questionnaires were developed according to criteria
described by Boynton and Greenhalgh [19]. Staff nurses
ranked each study tool using a Likert scale between 1 (not
useful) and 5 (very useful). A convenient sample of partic-
ipants included in the survey consisted of neonatal nurses,
adequately trained to recognize neonatal pain through appro-
priate pain tools. Participants’ demographic characteristics
(educational background and NICU experience) were col-
lected.
2.4. Patients’ Data. Demographic and medical data were
collected for every patient, by accessing electronic medical
charts (Neocare). Data included gender, GA, birth weight,
number of scores indicative of pain (score > 6), and modality
of analgesic intervention in case of pain (score > 6).
2.5. Data Analysis. The two cohorts of neonates, respectively,
evaluated in 𝑡1 and 𝑡2, were compared regarding patient
characteristics at birth with Student’s 𝑡-test. Answers to ques-
tionnaires related to EDIN scale and EDIN6, administered to
nurses, respectively, in 𝑡0 and 𝑡3, were expressed as percent-
ages of answers based on a 5-point Likert scale (very low, low,
medium, high, and very high) and, at a later stage, they were
compared using Fisher’s exact test. Statistical significance was
set at the 0.05 level. All statistical analyses were performed
using Sigmastat Excel for Windows.
3. Results
3.1. Patient Population-EDIN Score. During the study period,
all neonates admitted to the NICU and Medium Care were
included in the survey. Demographic and clinical data related
to the two cohorts are shown in Table 2. In 𝑡1 EDIN scale
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Table 1: EDIN6 scale (modified by Debillon 2001: E´chelle Douleur Inconfort Nouveau-Ne´), integrated by gestational age as a sixth item.
Item Description Score
(1) Facial activity
Relaxed facial activity 0
Transient grimaces with frowning, lip purse, and chin quiver 1
Frequent grimaces, lasting grimaces 2
Permanent grimaces resembling crying or blank face 3
(2) Body movements
Relaxed body movements 0
Transient agitation, often quiet 1
Frequent agitation but can be calmed down 2
Permanent agitation with contraction of fingers and toes and
hypertonia of limbs or infrequent, slow movements and prostration 3
(3) Quality of sleep
Falls asleep easily 0
Falls asleep with difficulty 1
Frequent, spontaneous arousals, independent of nursing, restless sleep 2
Sleepless 3
(4) Quality of contact with nurses
Smiles, attentive to voice 0
Transient apprehension during interactions with nurses 1
Difficulty communicating with nurses. Cries in response to minor
stimulation 2
Refuses to communicate with nurses. No interpersonal rapport.
Moans without stimulation 3
(5) Consolability
Quiet, total relaxation 0
Calms down quickly in response to stroking or voice or with sucking 1
Calms down with difficulty 2
Disconsolate. Sucks desperately 3
(6) Postmenstrual age
Gestational age > 37wks 0
Gestational age 33–37wks 1
Gestational age < 33wks 2
Table 2: Demographic data related to the group studied in 𝑡1 and 𝑡2.
𝑇1 (𝑛 = 195) 𝑇2 (𝑛 = 138) p
Gestational age, mean (ds) 35,1 (±4) 35,2 (±3,5) 0.91
Birth weight, mean (ds) 2340 g (±919 g) 2302 g (±860 g) 0.69
Gender (M/F) 107/88 71/67 0.58
M: male; F: female.
was applied to 195 neonates, for a total number of 9193 assess-
ments. 1844 (20% of the records) were performed in neonates
with PMA < 33wks (1st group); 4517 (49%) in neonates with
PMA33–37wks (2nd group); and 2832 (31%) in neonateswith
PMA > 37wks (3rd group). Edin scores > 6 detected pain
only in 55 out of 9193 records (0,6%) and were almost equally
distributed in the population: 17 assessments were related to
the 1st group (0,9%), 10 assessments to the 2nd group (0,2%),
and 25 assessments to the 3rd group (0,9%). As score > 6
suggests prolonged pain, analgesic interventions, both phar-
macological and nonpharmacological, were recorded. An
extra analgesic pharmacological strategy was adopted only in
22 cases (40%), 12 ofwhich in the 1st group, 1 in the 2nd group,
and 9 in the 3rd group. In 𝑡2 pain was assessed with EDIN6
in 138 neonates, for a total number of 7267 scores. 1478 of the
records (20%) were performed in the 1st group; 2595 (36%)
in the 2nd group; and 3200 (44%) in the 3rd group. As for the
first cohort, distribution of scores remained asymmetrical, in
every group studied. However, in the second cohort, EDIN6
basal scores were higher in the 1st and 2nd group, while they
remained similar in the 3rd group. Score > 6 was recorded
only in 117 assessments out of 7267 (1,6%): 50 reports in PMA
< 33wks (3,3%), 26 reports in PMA 33–37wks (0,9%), and
41 reports in PMA > 37wks (1,2%); see Table 3. As before,
the association between score > 6 and analgesic intervention
was recorded. Although EDIN6 scores > 6 almost doubled,
if compared to EDIN ones, in group 1 (3,3% versus 0,9%, 𝑝
= 0,001) and in group 2 (0,9% versus 0,2%, 𝑝 = 0,001), the
absolute number of observations indicative of pain remained
low in both of the study periods (55–0,6% in 𝑇1, 117–1,5%
in 𝑇2). Extra control-pain pharmacological measures were
necessary only in 27 cases, corresponding to the 23% of
prolonged pain conditions (10 interventions in the 1st group,
8 interventions in the 2nd group, and 9 interventions in the
3rd group). Figure 1 shows a comparison of pain scores by
EDIN and EDIN6 for different PMA categories.
Interrater reliability was very good within both periods
(Cohen’s Kappa was 0,82 and 0,86 in periods 𝑇1 and 𝑇2,
respectively).
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Table 3: Results expressed as score indicative of pain (>6)/total number of evaluation.
EDIN (%) EDIN6 (%) 𝑝
Gestational age < 33wks 17/1734 (0,9) 50/1472 (3,3) <0.001
Gestational age 33–37wks 10/4335 (0,2) 26/2606 (1) <0.001
Gestational age > 37wks 25/2624 (0,9) 41/3189 (1,3) 0.26
Total population 52/8693 (0,5) 117/7267 (1,6) <0.001
Pain detection = Score > 6/Total evaluation (%).
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Figure 1: Percentage of pain assessment by (a) EDIN and (b) EDIN6 for PMA < 33wks (dashed line); PMA 33–37wks (continuous line); and
PMA > 37wks (dotted line). The majority of scores (99.4% in 𝑡1; 98,4% in 𝑡2) are indicative of “No-pain” state by all different PMA groups.
EDIN: E´chelle de Douleur et d’Inconfort du Nouveau-ne´; PMA: postmenstrual age.
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Figure 2: Variable clinical experience in the neonatal intensive care
(years) of the nursing staff participating in the survey.
3.2. Nursing Staff Survey. A total of 70 neonatal nurses
participated in the survey. All were specifically trained for
neonatal pain management, although with a variable clinical
experience (see Figure 2). Results from scale evaluation
through the five Likert-based questionnaires are summarized
in Table 4. As shown, nurses highly appreciated EDIN6
introduction in clinical practice.
Part of the study results was presented at the Congress of
Joint European Neonatal Societies, Budapest, 16th–20th 2015
(jENS 2015) [20].
4. Discussion
The neurophysiological basis of biological readiness to expe-
rience pain early in fetal development is well known [1].
However, response to pain may vary markedly across the
age range of prematurity because of incomplete motor mech-
anisms required to communicate discomfort to caregivers
[21, 22]. Many algometric scales have been introduced as
a tool to recognize neonatal pain, both acute and chronic.
Identifying prolonged pain is clinically relevant as it interferes
with growth and altered pain response later in life [23–25].
Pain-related stress in newborns, especially in preterm babies,
has been shown to impact negatively on brain development
and to alter neuroendocrine stress response (hypothalamic-
pituitary-adrenal axis), leading to cognitive and behavioral
impairment [26–29]. Recently, human epigenetic research
has focused on the association between early pain experience
in pretermbabies and behavioral impairment later in life [30].
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Table 4: EDIN6 versus EDIN. Comparison of answers to the questionnaire (𝑡3 versus 𝑡0). Percentages of opinion “medium,” “high,” and “very
high” (%) are shown.
EDIN (%) EDIN6 (%) 𝑝
Convenience 49/70 (70) 64/70 (91,4) 0.002
Adequacy to assess neonatal pain in NICU 12/70 (17,1) 55/70 (78,5) <0.001
Influence on nurse’s analgesic strategy 14/70 (20) 70/70 (100) <0.001
Influence on physician’s analgesic strategy 10/70 (14,2) 46/70 (65,7) <0.001
Adequacy to assess pain in PCA < 37 9/70 (12,8) 50/70 (71,4) <0.001
Adequacy to assess pain in sedated neonates 16/70 (22,8) 50/70 (71,4) <0.001
Adequacy to assess pain in predischarge neonate 55/70 (78,5) 61/70 (87,1) 0.26
Correlation with subjective perception 23/70 (46) 56/70 (80) <0.001
Epigenetics seem to have a role, by altering the transcriptional
functionality of the serotonin transporter gene (SLC6A4
methylation), which was found to be predictive of infant
temperament at 3 months of age [31]. Although research
has focused on developmental nociception [32], networks
and pathways involved in pain perception are not completely
unveiled [8]. As a consequence, pain assessment methods
are still rudimentary [8]. Among the available validated tools
for acute/prolonged neonatal pain assessment, N-PASS and
COMFORTneo are valuable options. The latter is a monodi-
mensional behavioral scale to evaluate both pain and distress
in the NICU. It was modified from the COMFORT scale,
showing preliminary reliability [11]. Conversely, N-PASS is a
multimodal scale and takes into account both physiological
and behavioral items. It is actually the only scale to investigate
vital signs in the context of prolonged pain. Additional points
for prematurity are provided, in order to level out their pain
response to full-term infants [10]. EDIN scale does not take
into account GA [9], which is a relevant developmental deter-
minant in pain perception, as it represents neonatal maturity
[33, 34]. Ancora et al. provided evidence on the influence of
GA and PMA on pain expression with an impact on EDIN
score [16]. In the present prospective observational study, we
investigated whether introducing GA as a sixth item to assess
pain could effectively improve prolonged pain measurement
in preterm infants. Our results from the first phase of the
study (𝑡1) show a complete overlapping distribution of scores
for the three categories of GA. Moreover, 99.4% of the scores
obtained continuously in 60 days of data collection (𝑡1) are
indicative of the absence of pain for all different GA groups
(see Figure 1). These data are not comparable to those from
the previous study byAncora et al. [16], as we did not perform
a multivariate analysis. From our results we can make two
assumptions: firstly we could state that both the current “pain
protocol” based on pain guidelines of the Italian Society
of Neonatology [18] and analgosedation approach for each
hospitalized neonate are appropriate to maintain a state of
comfort in most cases. This may in part be explained by the
increasing healthcare awareness and commitment to prevent
and manage neonatal pain, as a result of a quality improve-
ment training program. Secondly, we could speculate that
EDIN scale, applied as proposed by Debillon et al. [9], might
not be fully adequate to assess prolonged pain in preterm
infants. Some of its specific behavioral items (quality of sleep
or contact with nurses) are not straightforward but rather
hard to identify in the immature neonates. Despite that, they
represent pivotal elements for a comprehensive evaluation,
especially in the hands of trained staff [9]. On the other hand,
GA could be a missing key item in the EDIN assessment of
neonatal pain. It is easy to add in an objective way, with no
need for further time-consuming analysis.
In the second phase of the study the three categories of
GA showed a different distribution of pain score; as expected,
the more premature were the babies the higher were the
basal scores. Nevertheless, even in the second period, the
majority of scores were indicative of “No-pain” state by all
different PMA groups. This fact probably happened because
most babies had a very low basal score of EDIN and, even
augmented by the points of the prematurity, they did not
reach the level indicative of pain (>6). However, in 𝑡2 the per-
centages of pretermbabieswith a score indicative of painwere
significantly higher than in 𝑡1; we conclude that the use of
EDIN6 allowed us to point out the presence of preterm babies
(fortunately few) who still needed an additional analgesic
intervention. This explanation is strengthened by bedside
nurses’ judgment, although subjective itself, which strongly
advocated for EDIN6 use.
In case of pain (score > 6), nonpharmacological measures
were employed in most cases. The need for pharmacological
additive intervention, always supported by medical advice,
was only 40% in 𝑡1 and 23% in 𝑡2.
Limitations. The study population is very heterogeneous,
as no exclusion criteria were considered. Surgical patients,
especially those undergoing thoracic/abdominal surgery, are
more exposed to pain than other patients.Moreover, different
LOS can add further dishomogeneity, as well as the inclusion
of the first day of life, which could lead itself to potential
confounding stimuli, related to the delivery and early postna-
tal phase. Nevertheless, we believe that a significant number
of term and preterm infants included in the study could be
highly representative of NICU patients. Moreover, the possi-
bility to survey a nursing staff, which was adequately trained
for neonatal pain assessment, is another strength of the study,
providing valuable insights into user’s perspective.
As a proper management of neonatal pain is imperative
to improve neonatal clinical practice, searching for a reliable
measure of infant pain, especially of that born preterm,
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remains a challenge. Further studies are needed to identify
a “gold standard” chronic pain assessment tool, suitable for
the lowest GA groups.
5. Conclusions
Wereported the results of the implementation in ourNICUof
the EDIN6 scale, a modified EDIN scale specifically designed
to evaluate prolonged pain in different PMA categories of
prematurity. Compared to EDIN scale, EDIN6 seems a valu-
able integrative tool in the management of preterm babies.
Nursing staff perceived EDIN6 to be more suitable for pain
assessment in the less mature infants.
Appendix
Questionnaire Administered to
Nursing Staff (𝑛 = 70) for Evaluation of
EDIN (𝑡0) and EDIN6 (𝑡3) Scale
(1) How long have you been working in a Neonatal
Intensive Care Unit?
(a) <1 year
(b) 1–3 years
(c) 3–6 years
(d) 6–10 years
(e) >10 years
(2) In your opinion, how would you evaluate your train-
ing on neonatal pain
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(3) What is your knowledge of the neonatal painmanage-
ment procedure of the NICU you’re working in?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(4) In your opinion, is the scale useful?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(5) In your opinion, is the scale adequate for pain assess-
ment in the NICU?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(6) In your opinion, how much the scale score influence
nurse’s management of neonatal pain
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(7) In your opinion, how much the scale score influences
physician’s management of neonatal pain
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(8) According to you, is the scale adequate for pain
assessment in the preterm?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(9) According to you, is the scale adequate for pain
assessment in a sedated patient?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
(10) According to you, is the scale adequate for pain
assessment in the pre-discharge phase?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
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(11) According to you, does the scale correspond to your
subjective perception of the neonatal pain?
(a) very high
(b) high
(c) medium
(d) low
(e) very low
Abbreviations
GA: Gestational age
EDIN: E´chelle de Douleur et d’Inconfort du
Nouveau-ne´
LOS: Length of stay
NICU: Neonatal Intensive Care Unit
N-PASS: Neonatal Pain, Agitation, Sedation Scale
PMA: Postmenstrual age.
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